109 related articles for article (PubMed ID: 23623928)
1. Regulating the regulators in cancer-immunosuppression in multiple myeloma (MM).
Feyler S; Selby PJ; Cook G
Blood Rev; 2013 May; 27(3):155-64. PubMed ID: 23623928
[TBL] [Abstract][Full Text] [Related]
2. Immunodeficiency and immunotherapy in multiple myeloma.
Pratt G; Goodyear O; Moss P
Br J Haematol; 2007 Sep; 138(5):563-79. PubMed ID: 17686051
[TBL] [Abstract][Full Text] [Related]
3. Cellular immunotherapy for multiple myeloma.
Rosenblatt J; Avigan D
Best Pract Res Clin Haematol; 2008 Sep; 21(3):559-77. PubMed ID: 18790455
[TBL] [Abstract][Full Text] [Related]
4. Peptide-based immunotherapy for multiple myeloma: current approaches.
Zhou FL; Meng S; Zhang WG; Wei YC; Cao XM; Bai GG; Wang BY
Vaccine; 2010 Aug; 28(37):5939-46. PubMed ID: 20619381
[TBL] [Abstract][Full Text] [Related]
5. Immune regulation in multiple myeloma: the host-tumour conflict.
Cook G; Campbell JD
Blood Rev; 1999 Sep; 13(3):151-62. PubMed ID: 10527267
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy in multiple myeloma--possibility or probability?
Harrison SJ; Cook G
Br J Haematol; 2005 Aug; 130(3):344-62. PubMed ID: 16042684
[TBL] [Abstract][Full Text] [Related]
7. Role of the Immune Response in Disease Progression and Therapy in Multiple Myeloma.
Lee SJ; Borrello I
Cancer Treat Res; 2016; 169():207-225. PubMed ID: 27696265
[TBL] [Abstract][Full Text] [Related]
8. Immunology and immunotherapeutic approaches in multiple myeloma.
Schlude C; Beckhove P
Recent Results Cancer Res; 2011; 183():97-109. PubMed ID: 21509682
[TBL] [Abstract][Full Text] [Related]
9. Current concepts in immunotherapy for the treatment of colorectal cancer.
Indar A; Maxwell-Armstrong CA; Durrant LG; Carmichael J; Scholefield JH
J R Coll Surg Edinb; 2002 Apr; 47(2):458-74. PubMed ID: 12018689
[TBL] [Abstract][Full Text] [Related]
10. Immune alterations in untreated and treated multiple myeloma.
Dasanu CA
J Oncol Pharm Pract; 2012 Jun; 18(2):257-63. PubMed ID: 21859744
[TBL] [Abstract][Full Text] [Related]
11. New Strategies in Multiple Myeloma: Immunotherapy as a Novel Approach to Treat Patients with Multiple Myeloma.
Neri P; Bahlis NJ; Lonial S
Clin Cancer Res; 2016 Dec; 22(24):5959-5965. PubMed ID: 27797968
[TBL] [Abstract][Full Text] [Related]
12. Idiotype-specific immunotherapy in multiple myeloma: suggestions for future directions of research.
Bogen B; Ruffini PA; Corthay A; Fredriksen AB; Frøyland M; Lundin K; Røsjø E; Thompson K; Massaia M
Haematologica; 2006 Jul; 91(7):941-8. PubMed ID: 16818282
[TBL] [Abstract][Full Text] [Related]
13. Cancer immunosuppression and autoimmune disease: beyond immunosuppressive networks for tumour immunity.
Kim R; Emi M; Tanabe K
Immunology; 2006 Oct; 119(2):254-64. PubMed ID: 17005005
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of multiple myeloma: the start of a long and tortuous journey.
Harrison SJ; Cook G; Nibbs RJ; Prince HM
Expert Rev Anticancer Ther; 2006 Dec; 6(12):1769-85. PubMed ID: 17181491
[TBL] [Abstract][Full Text] [Related]
15. Is secretion of tumour-specific antigen important for cancer eradication by CD4(+) T cells?--Implications for cancer immunotherapy by adoptive T cell transfer.
Corthay A; Lorvik KB; Bogen B
Scand J Immunol; 2011 Jun; 73(6):527-30. PubMed ID: 21388431
[TBL] [Abstract][Full Text] [Related]
16. How immunotherapy can enhance the response to other modalities and improve outcome and quality of life.
Liu WM; Meyer B; Dalgleish AG
J BUON; 2009 Sep; 14 Suppl 1():S103-9. PubMed ID: 19785052
[TBL] [Abstract][Full Text] [Related]
17. Effect of haematological malignancies and their treatment on host defence factors.
Hersh EV; Gutterman JU; Mavligit GM
Clin Haematol; 1976 Jun; 5(2):425-48. PubMed ID: 780032
[TBL] [Abstract][Full Text] [Related]
18. Active immunotherapy of multiple myeloma.
Houet L; Veelken H
Eur J Cancer; 2006 Jul; 42(11):1653-60. PubMed ID: 16797966
[TBL] [Abstract][Full Text] [Related]
19. Current Strategies for the Immunotherapy of Multiple Myeloma.
Luetkens T; Yousef S; Radhakrishnan SV; Atanackovic D
Oncology (Williston Park); 2017 Jan; 31(1):55-63. PubMed ID: 28090624
[TBL] [Abstract][Full Text] [Related]
20. Humoral immunotherapy of multiple myeloma: perspectives and perplexities.
Di Bernardo A; Macor P; Guarnotta C; Franco G; Florena AM; Tedesco F; Tripodo C
Expert Opin Biol Ther; 2010 Jun; 10(6):863-73. PubMed ID: 20367529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
